GO:0035472 choriogonadotropin hormone receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035472 choriogonadotropin hormone receptor activity is the molecular function of binding choriogonadotropin hormone (CG) to initiate a change in cell activity, canonically mediated by LHCGR.
• The receptor is a glycoprotein hormone receptor with a large extracellular N-terminal domain that contacts both subunits of human choriogonadotropin.
• Full-length glycoprotein hormone receptor signalling complexes reveal the structural basis of hormone binding and G-protein activation.
• Receptor homomers display activity-regulated hormone-binding cooperativity, meaning binding at one site influences binding at others.
• Trafficking of the luteinizing hormone receptor differentially directs signal activation between luteinizing hormone and chorionic gonadotropin.
• N-linked and O-linked glycosylation sites modulate the activity of chorionic gonadotropin in cells expressing rat LH/CG receptor and FSHR.
Description
Choriogonadotropin hormone receptor activity (GO:0035472) is a molecular function defined as combining with the choriogonadotropin hormone to initiate a change in cell activity. This activity is central to reproductive endocrinology because it mediates the cellular response to chorionic gonadotropin, a hormone critical for maintenance of pregnancy and gonadal function. The receptor responsible for this activity is the luteinizing hormone/choriogonadotropin receptor (LHCGR), a member of the glycoprotein hormone receptor family. Researchers study GO:0035472 to understand how a single receptor can bind two related hormones, LH and CG, and translate that binding into distinct intracellular signals. The structural and functional basis of this activity has been illuminated by cryo-EM structures of full-length glycoprotein hormone receptor signalling complexes, mutational analysis of hormone-receptor contacts, and studies of receptor cooperativity. Because LHCGR is a key therapeutic target in reproductive disorders and certain cancers, precise annotation of GO:0035472 supports both basic discovery and translational research.
choriogonadotropin hormone receptor activity At A Glance
| GO ID | GO:0035472 |
|---|---|
| GO term | choriogonadotropin hormone receptor activity |
| Ontology | molecular_function |
| Synonym | CG receptor activity; chorio-gonadotrophin receptor activity; chorionic gonadotropin hormone receptor |
| Definition | Combining with the choriogonadotropin hormone to initiate a change in cell activity. |
| Major function | Binding of choriogonadotropin hormone to initiate intracellular signalling, primarily through LHCGR. |
| Canonical receptor | LHCGR (luteinizing hormone/choriogonadotropin receptor). |
| Structural feature | Large extracellular N-terminal domain that contacts both subunits of human choriogonadotropin. |
| Regulatory feature | Activity-regulated hormone-binding cooperativity across receptor homomers. |
What Is GO:0035472?
In our own words, GO:0035472 describes the function of a receptor protein that specifically binds choriogonadotropin hormone (CG) and, upon binding, triggers a change in the receiving cell. This activity is not merely a binding event; it encompasses the initiation of downstream signalling that alters cell behavior. The official QuickGO definition is: Combining with the choriogonadotropin hormone to initiate a change in cell activity. The term is a molecular_function and includes synonyms such as CG receptor activity, chorio-gonadotrophin receptor activity, and chorionic gonadotropin hormone receptor. The canonical gene product annotated with this activity is LHCGR, which also binds luteinizing hormone.
Why Is choriogonadotropin hormone receptor activity Important in Cell Biology?
GO:0035472 is important because it defines the first step in cellular responses to chorionic gonadotropin, a hormone essential for pregnancy maintenance and gonadal steroidogenesis. Dysregulation of this activity is linked to reproductive disorders, and the receptor is a target in conditions such as precocious puberty and certain hormone-dependent tumors. Understanding the molecular details of this activity also informs drug design, as allosteric and hormonal regulation of LHCGR can be exploited therapeutically. Moreover, the differential signalling between LH and CG at the same receptor highlights how trafficking and glycosylation fine-tune this activity.
• Mediates the cellular response to chorionic gonadotropin, a key hormone in pregnancy and gonadal function.
• Provides a paradigm for understanding glycoprotein hormone receptor activation and cooperativity.
• Informs reproductive medicine, including fertility treatments and contraception.
• Relevant to hormone-dependent cancers where LHCGR expression is altered.
• Glycosylation of the hormone modulates receptor activity, linking post-translational modifications to function.
• Trafficking of the receptor differentially directs LH versus CG signalling.
• Mutational analysis of receptor-hormone contacts reveals determinants of binding specificity.
• Alternatively folded hormone analogs can affect biological activity, offering tools for probing the receptor.
Molecular Mechanism of choriogonadotropin hormone receptor activity
Hormone Binding and Receptor Contact
In simple terms: The hormone grabs onto the receptor's outer domain, like a key fitting into a lock.
Choriogonadotropin hormone binds to the large extracellular N-terminal domain of LHCGR. Mutational analysis has shown that this region contacts both subunits of human choriogonadotropin, providing a structural basis for high-affinity binding. The full-length receptor signalling complex structures reveal how the hormone engages the receptor ectodomain and induces conformational changes.
Receptor Cooperativity and Homomer Assembly
In simple terms: Receptors can work together, so binding one hormone makes it easier for others to bind.
Glycoprotein hormone receptors can form homomers, and hormone binding exhibits activity-regulated cooperativity. This means that the binding of one hormone molecule can influence the binding affinity at other sites within the receptor oligomer, fine-tuning the cellular response.
Signal Transduction and Differential Activation
In simple terms: Once the hormone is bound, the receptor sends different signals depending on how it is trafficked inside the cell.
Upon hormone binding, LHCGR activates G-protein-mediated signalling pathways. Recent evidence indicates that trafficking of the luteinizing hormone receptor directs differential signal activation between luteinizing hormone and chorionic gonadotropin, meaning the same receptor can produce distinct downstream effects depending on the ligand and its intracellular itinerary.
Glycosylation and Hormone Activity
In simple terms: Sugar chains attached to the hormone affect how well it can activate the receptor.
N-linked and O-linked glycosylation sites on chorionic gonadotropin influence its activity in cells expressing the rat LH/CG receptor and FSHR. These post-translational modifications modulate the potency of the hormone-receptor interaction, adding another layer of regulation to GO:0035472.
Allosteric and Hormonal Regulation
In simple terms: Other molecules can bind the receptor at different sites to tweak its activity up or down.
The luteinizing hormone/chorionic gonadotropin receptor is subject to both hormonal and allosteric regulation. Allosteric modulators can alter the receptor's response to hormone, providing potential therapeutic avenues and expanding our understanding of GO:0035472 beyond simple hormone binding.
Key Genes Involved in GO:0035472 choriogonadotropin hormone receptor activity
The following genes and proteins are directly implicated in choriogonadotropin hormone receptor activity (GO:0035472) or its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LHCGR | Binds choriogonadotropin hormone to initiate signalling; canonical receptor for GO:0035472 | Central to reproductive endocrinology and target of mutational analysis |
| CGA | Alpha subunit of glycoprotein hormones including CG; contacts receptor N-terminal region | Mutational studies show its role in receptor binding |
| CGB | Beta subunit of chorionic gonadotropin; confers specificity to CG | Key for hormone-receptor interaction and signalling |
| FSHR | Follicle-stimulating hormone receptor; related glycoprotein hormone receptor | Used in comparative studies of glycosylation effects on receptor activity |
| LHB | Luteinizing hormone beta subunit; shares receptor with CG | Differential signalling between LH and CG at LHCGR |
| GNA S | Stimulatory G protein alpha subunit; mediates downstream signalling from LHCGR | Implicated in signal transduction upon receptor activation |
| ARRB1 | Beta-arrestin 1; involved in receptor desensitization and internalization | Potential regulator of LHCGR trafficking and signalling |
| ARRB2 | Beta-arrestin 2; involved in receptor internalization | May influence differential signalling |
| GNB1 | G protein beta subunit; part of heterotrimeric G protein complex | Contributes to signal transduction from glycoprotein hormone receptors |
| GNG2 | G protein gamma subunit; part of heterotrimeric G protein complex | Component of the signalling complex |
| PKA | Protein kinase A; downstream effector of cAMP signalling | Mediates many cellular responses to LHCGR activation |
| PKC | Protein kinase C; downstream effector in some LHCGR signalling pathways | Contributes to differential signalling |
| CREB1 | cAMP response element-binding protein; transcription factor activated downstream of PKA | Links receptor activity to gene expression changes |
| STAR | Steroidogenic acute regulatory protein; involved in steroidogenesis downstream of LHCGR | Marker of functional LHCGR signalling in gonadal cells |
| CYP11A1 | Cholesterol side-chain cleavage enzyme; steroidogenic enzyme | Downstream target of LHCGR signalling |
| CYP17A1 | 17-alpha-hydroxylase; steroidogenic enzyme | Downstream target of LHCGR signalling |
| HSD3B2 | 3-beta-hydroxysteroid dehydrogenase; steroidogenic enzyme | Downstream target of LHCGR signalling |
How Is choriogonadotropin hormone receptor activity Regulated?
The activity of choriogonadotropin hormone receptor is regulated at multiple levels. Hormonal regulation occurs through the availability of the ligand itself, and allosteric modulators can fine-tune receptor responsiveness. Activity-regulated cooperativity across receptor homomers provides a mechanism for amplifying or dampening signals based on hormone concentration. Trafficking of the receptor between intracellular compartments and the cell surface differentially directs signal activation between LH and CG, adding a spatial dimension to regulation. Additionally, glycosylation of the hormone affects its potency, indirectly regulating receptor activity. These layers ensure that GO:0035472 is not a simple on/off switch but a dynamically controlled function.
choriogonadotropin hormone receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LHCGR | Precocious puberty, Leydig cell hypoplasia, infertility | Knockout or point-mutation cell models to assess signalling |
| CGB | Gestational trophoblastic disease, ectopic hormone production | Overexpression of wild-type vs. glycosylation mutants |
| LHCGR | Hormone-dependent cancers | Knock-in of constitutively active mutants in cancer cell lines |
| FSHR | Ovarian dysgenesis, spermatogenic failure | Comparative studies with LHCGR in knockout backgrounds |
| ARRB1/ARRB2 | Altered receptor desensitization in reproductive tissues | Knockout of arrestins to study trafficking and signalling |
Reproductive Disorders
Mutations or dysregulation of LHCGR, the primary receptor for GO:0035472, are associated with reproductive disorders such as precocious puberty, Leydig cell hypoplasia, and infertility. The receptor's role in mediating chorionic gonadotropin signalling makes it a critical node in pregnancy maintenance and gonadal function.
Hormone-Dependent Cancers
LHCGR expression has been detected in certain hormone-dependent tumors, where choriogonadotropin hormone receptor activity may contribute to proliferative signalling. Targeting this activity could offer therapeutic strategies in cancers that exploit gonadotropin signalling.
Glycosylation-Related Pathologies
Alterations in glycosylation of chorionic gonadotropin can affect its activity at the receptor, potentially contributing to conditions such as gestational trophoblastic disease. Understanding these modifications helps explain variable clinical presentations.
From choriogonadotropin hormone receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LHCGR abolish choriogonadotropin hormone receptor activity? | LHCGR knockout cell line (e.g., HEK293 or Leydig cell line) |
| Which residues mediate hormone binding? | Point-mutation knock-in of LHCGR at predicted contact sites |
| How does glycosylation affect hormone potency? | Overexpression of glycosylation-site mutants of CGB in receptor-expressing cells |
| What is the role of receptor cooperativity? | Knock-in of dimerization-interface mutants and binding assays |
| How does trafficking influence differential signalling? | Tagged knock-in of LHCGR with fluorescent tags for live imaging |
| Can allosteric modulators alter receptor activity? | Overexpression of LHCGR followed by treatment with allosteric compounds |
How to Study the choriogonadotropin hormone receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of receptor-hormone-G protein complex | Understanding activation mechanism |
| Site-directed mutagenesis | Effect of specific amino acid changes on binding | Mapping hormone-receptor interface |
| Radioligand binding | Affinity and cooperativity of hormone binding | Quantifying receptor activity |
| Glycosylation profiling | Presence and type of glycan modifications | Correlating glycosylation with activity |
| Live-cell imaging | Receptor trafficking and localization | Studying differential signalling |
| cAMP assays | Downstream second messenger production | Measuring functional receptor activation |
| Allosteric modulator screening | Modulation of receptor response | Drug discovery |
| Transcriptomics | Changes in gene expression upon receptor activation | Identifying downstream targets |
Structural Biology (Cryo-EM)
Cryo-electron microscopy of full-length glycoprotein hormone receptor signalling complexes has revealed the architecture of the hormone-receptor-G protein assembly, providing atomic-level insights into GO:0035472.
Mutagenesis and Binding Assays
Site-directed mutagenesis combined with radioligand binding assays identifies residues critical for hormone contact and receptor activation, as demonstrated for the N-terminal region of LHCGR.
Glycosylation Analysis
Mass spectrometry and lectin-based assays characterize N-linked and O-linked glycosylation of chorionic gonadotropin, linking these modifications to receptor activity.
Live-Cell Imaging and Trafficking
Fluorescently tagged receptors and ligands enable real-time tracking of trafficking and its impact on differential signalling between LH and CG.
How CRISPR Can Be Used to Study GO:0035472 choriogonadotropin hormone receptor activity
Knockout
CRISPR knockout of LHCGR can abolish choriogonadotropin hormone receptor activity, providing a clean background to study downstream signalling and to validate specificity of hormonal responses.
Point Mutation
Point mutations introduced by CRISPR base editing or HDR can mimic naturally occurring variants or probe specific residues involved in hormone binding and receptor activation, as guided by mutational analyses.
Knock-in
Knock-in of tagged LHCGR (e.g., fluorescent or epitope tags) allows real-time visualization of receptor trafficking and its role in differential signalling between LH and CG.
Overexpression
CRISPR activation or lentiviral overexpression of LHCGR and its ligands enables gain-of-function studies to dissect the signalling cascade and test allosteric modulators.
How EDITGENE Supports choriogonadotropin hormone receptor activity Research
Researchers studying choriogonadotropin hormone receptor activity-related genes often need to determine whether a candidate gene is causally involved in hormone binding, signal transduction, or downstream cellular responses. EDITGENE provides a comprehensive suite of CRISPR-based services to create precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for choriogonadotropin hormone receptor activity research.
Frequently Asked Questions About choriogonadotropin hormone receptor activity
What is choriogonadotropin hormone receptor activity?
It is a molecular function (GO:0035472) defined as combining with choriogonadotropin hormone to initiate a change in cell activity, primarily mediated by the LHCGR receptor.
What genes are involved in choriogonadotropin hormone receptor activity?
The primary gene is LHCGR, which encodes the receptor. The hormone subunits are encoded by CGA and CGB. Other related genes include FSHR and LHB.
What is the role of LHCGR in choriogonadotropin hormone receptor activity?
LHCGR binds choriogonadotropin hormone and triggers intracellular signalling, serving as the canonical receptor for this activity.
How is choriogonadotropin hormone receptor activity regulated?
It is regulated by hormone availability, receptor cooperativity, allosteric modulators, glycosylation, and receptor trafficking.
What diseases are associated with choriogonadotropin hormone receptor activity?
Dysregulation is linked to reproductive disorders such as precocious puberty and infertility, as well as certain hormone-dependent cancers.
How can CRISPR be used to study choriogonadotropin hormone receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of receptor function and signalling.
What methods are used to study choriogonadotropin hormone receptor activity?
Common methods include cryo-EM, mutagenesis, radioligand binding, glycosylation analysis, live-cell imaging, and cAMP assays.
What is the structure of the choriogonadotropin hormone receptor?
It is a glycoprotein hormone receptor with a large extracellular N-terminal domain that contacts both subunits of the hormone, as revealed by cryo-EM and mutational studies.
How does glycosylation affect choriogonadotropin hormone receptor activity?
N-linked and O-linked glycosylation of the hormone modulates its potency in activating the receptor.
What is the difference between LH and CG signalling at the receptor?
Trafficking of the receptor differentially directs signal activation between LH and CG, leading to distinct downstream effects.
Conclusion
Choriogonadotropin hormone receptor activity (GO:0035472) is a fundamental molecular function that governs cellular responses to chorionic gonadotropin, with LHCGR as its principal mediator. Structural, biochemical, and genetic studies have elucidated the binding interface, cooperativity, glycosylation effects, and trafficking-dependent signalling that define this activity. Its relevance to reproductive disorders and hormone-dependent cancers makes it a compelling target for both basic and translational research. CRISPR-based models offer powerful tools to dissect the precise roles of LHCGR and its partners, and EDITGENE provides the expertise to generate such models efficiently.
References
- 1. Duan J et al.. 2021. Structures of full-length glycoprotein hormone receptor signalling complexes.. Nature 598(7882):688-692 PMID: 34552239
- 2. Lazzaretti C et al.. 2025. Trafficking of luteinizing hormone receptor directs the differential signal activation between luteinizing hormone and chorionic gonadotropin.. Int J Biol Macromol 318(Pt 3):145247 PMID: 40517872
- 3. Zoenen M et al.. 2012. Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers.. Nat Commun 3:1007 PMID: 22893131
- 4. Segaloff DL et al.. 1990. Structure of the lutropin/choriogonadotropin receptor.. Recent Prog Horm Res 46:261-301; discussion 301-3 PMID: 2281186
- 5. Hong S et al.. 1998. The amino-terminal region of the luteinizing hormone/choriogonadotropin receptor contacts both subunits of human choriogonadotropin. I. Mutational analysis.. J Biol Chem 273(22):13835-40 PMID: 9593728
- 6. Lee SY et al.. 2021. Roles of N-linked and O-linked glycosylation sites in the activity of equine chorionic gonadotropin in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and follicle-stimulating hormone receptor.. BMC Biotechnol 21(1):52 PMID: 34482828
- 7. Shpakov AO. 2024. Hormonal and Allosteric Regulation of the Luteinizing Hormone/Chorionic Gonadotropin Receptor.. Front Biosci (Landmark Ed) 29(9):313 PMID: 39344322
- 8. Xing Y et al.. 2001. Alternatively folded choriogonadotropin analogs. Implications for hormone folding and biological activity.. J Biol Chem 276(50):46953-60 PMID: 11591722
